A phase III, multicentric, randomized single-blind study to evaluate the safety and the immunogenicity of El-Shaddai Biologicals varicella zoster vaccine in comparison to GlaxoSmithKline Biologicals Varilrixin healthy subjects aged 1 to 12 years.
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- 23 Nov 2011 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 08 Nov 2011 New trial record